[go: up one dir, main page]

Piganelli et al., 2002 - Google Patents

A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone

Piganelli et al., 2002

View PDF
Document ID
6279693448110982269
Author
Piganelli J
Flores S
Cruz C
Koepp J
Batinic-Haberle I
Crapo J
Day B
Kachadourian R
Young R
Bradley B
Haskins K
Publication year
Publication venue
Diabetes

External Links

Snippet

RESEARCH DESIGN AND METHODS Mice. NOD. scid breeding pairs were obtained either from the Jackson Laboratory (Bar Harbor, ME) or the breeding colony at the Barbara Davis Center. NOD, NOD. scid, and BDC-2.5-TCR-Tg/NOD (2.5 TCR Tg/NOD) mice were bred and …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings

Similar Documents

Publication Publication Date Title
Piganelli et al. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone
Delmastro et al. Oxidative stress and redox modulation potential in type 1 diabetes
Gunther et al. Carbon monoxide protects pancreatic β-cells from apoptosis and improves islet function/survival after transplantation
Chen et al. RAGE ligation affects T cell activation and controls T cell differentiation
Thomas et al. Beta cell destruction in the development of autoimmune diabetes in the non‐obese diabetic (NOD) mouse
US8470808B2 (en) Oxidant scavengers for treatment of type I diabetes or type II diabetes
Chen et al. MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity
Chambers et al. The role of nitric oxide and the unfolded protein response in cytokine-induced β-cell death
Sandeep et al. Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases
Chen Regulation of protein synthesis by the heme-regulated eIF2α kinase: relevance to anemias
Bruni et al. Regulated cell death seen through the lens of islet transplantation
Peltzer et al. Holding RIPK1 on the ubiquitin leash in TNFR1 signaling
Silveira et al. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self‐antigen‐specific immunoglobulin receptors
Liu et al. Phenotypic and functional switch of macrophages induced by regulatory CD4+ CD25+ T cells in mice
Henquin et al. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions
Hildeman et al. Reactive oxygen species regulate activation-induced T cell apoptosis
Mayer et al. AMP‐activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function
Kim et al. Essential role for signal transducer and activator of transcription-1 in pancreatic β-cell death and autoimmune type 1 diabetes of nonobese diabetic mice
Mabley et al. NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes
Tran et al. Discrete and complementary mechanisms of protection of β-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy
AU2002312194A1 (en) Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
Previte et al. Reactive oxygen species and their implications on CD4+ T cells in type 1 diabetes
Heitmeier et al. Role of cyclooxygenase-2 in cytokine-induced β-cell dysfunction and damage by isolated rat and human islets
Zhang et al. Sumoylation modulates the susceptibility to type 1 diabetes
Abram et al. The modulation of enzyme indoleamine 2, 3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus